Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

BANDUNG, itb.ac.id - The PINTAR Diagnostics team from the School of Life Sciences and Technology (SLST), Institut Teknologi ...

Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...

Please provide your email address to receive an email when new articles are posted on . A CRISPR-Cas9-based therapy reduced transthyretin levels in patients with hereditary amyloidosis and ...

High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP), and it's important for retail traders to take note. \This activity came to our attention today through ...

One of these players is a pharma giant trading for a dirt-cheap price today. The second stock here is a biotech company that’s recently proven the strength of its game-changing technology. 10 stocks ...